Nitrosamine Impurity Analysis
Nitrosamine Impurity Analysis is a specialized analytical methodology within impurity profiling that identifies and quantifies nitrosamine compounds in pharmaceutical substances and products, distinguished by its focus on carcinogenic N-nitroso structures arising from synthesis or degradation pathways.
413
Publications
15.1K
Citations
1.4K
Authors
431
Institutions
Publications per year
2017–2026
121
Parents
413
J. Nair, Hiroshi Ohshima, Marlin D. Friesen et al. · Carcinogenesis · 1985 · 200 citations
Inhibition of Nitrosamine Formation by Nondialyzable Melanoidins
Hiromichi Kato, In Eui Lee, Nguyễn Văn Chuyên et al. · Agricultural and Biological Chemistry · 1987 · 178 citations
Pharmacy, Biochemistry, Toxicology +12
1–5 of 413
1.4K
13
h-index
12
h-index
11
h-index
10
h-index
10
h-index
1–5 of 1.4K
431
United States Food and Drug Administration
Silver Spring, United States
12 h-index
62 publications
2.4K citations
Health Canada
Ottawa, Canada
12 h-index
36 publications
1.2K citations
Eastern Regional Research Center
Wyndmoor, United States
12 h-index
40 publications
1.1K citations
German Cancer Research Center
Heidelberg, Germany
11 h-index
36 publications
914 citations
AstraZeneca (United Kingdom)
Cambridge, United Kingdom
10 h-index
21 publications
1.2K citations
Heidelberg University
Heidelberg, Germany
10 h-index
28 publications
783 citations
Merck KGaA, Darmstadt (Germany)
Darmstadt, Germany
9 h-index
53 publications
3.2K citations

Agricultural Research Service
Washington, United States
8 h-index
19 publications
494 citations
1–8 of 431
40 publications · 1.7K citations
26
h-index
22 publications · 798 citations
17
h-index
Repository · 26 publications · 818 citations
15
h-index
14 publications · 987 citations
14
h-index
14 publications · 482 citations
12
h-index
1–5